Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon M Cook

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Virulence|June 27, 2013
Developing Galleria mellonella as a model host for human pathogensSimon M Cook, Jason D McArthur
Current Drug Targets|December 31, 2011
The role of streptokinase as a virulence determinant of Streptococcus pyogenes--potential for therapeutic targetingJason D McArthur, Simon M Cook, Carola Venturini, et al.
Molecular Microbiology|October 31, 2012
Streptokinase variants from Streptococcus pyogenes isolates display altered plasminogen activation characteristics - implications for pathogenesisSimon M Cook, Amanda Skora, Christine M Gillen, et al.
The Biochemical Journal|November 26, 2013
Site-restricted plasminogen activation mediated by group A streptococcal streptokinase variantsSimon M Cook, Amanda Skora, Mark J Walker, et al.
Biochemistry|June 2, 2015
Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal IsolatesDavid M P De Oliveira, Ruby H P Law, Diane Ly, et al.
Journal of Medicinal Chemistry|August 22, 2018
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in CancerBenjamin J Buckley, Ashraf Aboelela, Elahe Minaei, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Virulence|June 27, 2013
Developing Galleria mellonella as a model host for human pathogensSimon M Cook, Jason D McArthur
Current Drug Targets|December 31, 2011
The role of streptokinase as a virulence determinant of Streptococcus pyogenes--potential for therapeutic targetingJason D McArthur, Simon M Cook, Carola Venturini, et al.
Molecular Microbiology|October 31, 2012
Streptokinase variants from Streptococcus pyogenes isolates display altered plasminogen activation characteristics - implications for pathogenesisSimon M Cook, Amanda Skora, Christine M Gillen, et al.
The Biochemical Journal|November 26, 2013
Site-restricted plasminogen activation mediated by group A streptococcal streptokinase variantsSimon M Cook, Amanda Skora, Mark J Walker, et al.
Biochemistry|June 2, 2015
Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal IsolatesDavid M P De Oliveira, Ruby H P Law, Diane Ly, et al.
Journal of Medicinal Chemistry|August 22, 2018
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in CancerBenjamin J Buckley, Ashraf Aboelela, Elahe Minaei, et al.
Pageof 1